Pfizer/Biontech COVID-19 vaccine wins Swiss regulatory approval
Pfizer/Biontech COVID-19 vaccine wins Swiss regulatory approval

Swiss drugs regulator Swissmedic has authorised the COVID-19 vaccine from Pfizer and partner BioNTech, the agency said on Saturday, calling it the world’s first such approval under a standard procedure. Reuters reported.

Two months after receiving the application, Swissmedic granted authorisation for the vaccine for people aged 16 and older after a rolling review of documents being submitted.

Other countries have already approved it for emergency use to help curb the global coronavirus pandemic.